BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors. 2017

Chao Chen, and Jiemei Song, and Jinzheng Wang, and Chang Xu, and Caiping Chen, and Wei Gu, and Hongbin Sun, and Xiaoan Wen
Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing 210009, China; State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing 210009, China.

Herpesvirus-associated Ubiquitin-Specific Protease (HAUSP, also called USP7) interacts with and stabilizes Mdm2, and represents one of the first examples that deubiquitinases oncogenic proteins. USP7 has been regarded as a potential drug target for cancer therapy. Inhibitors of USP7 have been recently shown to suppress tumor cell growth in vitro and in vivo. Based on leading USP7 inhibitors P5091 and P22077, we designed and synthesized a series of thiazole derivatives. The results of in vitro assays showed that the thiazole compounds exhibited low micromolar inhibition activity against both USP7 enzyme and cancer cell lines. The compounds induced cell death in a p53-dependent and p53-independent manner. Taken together, this study may provide thiazole compounds as a new class of USP7 inhibitors.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000076084 Ubiquitin-Specific Peptidase 7 A ubiquitinyl hydrolase that deubiquitinates several proteins with critical roles in DNA REPAIR, cell growth, and survival, including TUMOR SUPPRESSOR PROTEIN P53; MDM-2 PROTEIN; and PTEN PHOSPHOHYDROLASE. It also stabilizes herpesvirus 1 trans-acting transcriptional protein VMW110 during HSV-1 infection, contributing to its function as a TRANS-ACTIVATOR. HAUSP Protein,Herpesvirus-Associated Ubiquitin-Specific Peptidase,USP7 Protein,Herpesvirus Associated Ubiquitin Specific Peptidase,Peptidase 7, Ubiquitin-Specific,Peptidase, Herpesvirus-Associated Ubiquitin-Specific,Ubiquitin Specific Peptidase 7,Ubiquitin-Specific Peptidase, Herpesvirus-Associated
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Chao Chen, and Jiemei Song, and Jinzheng Wang, and Chang Xu, and Caiping Chen, and Wei Gu, and Hongbin Sun, and Xiaoan Wen
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
December 2009, Bioorganic & medicinal chemistry letters,
Chao Chen, and Jiemei Song, and Jinzheng Wang, and Chang Xu, and Caiping Chen, and Wei Gu, and Hongbin Sun, and Xiaoan Wen
Synthesis and biological evaluation of thiazole derivatives as LbSOD inhibitors.
December 2019, Journal of enzyme inhibition and medicinal chemistry,
Chao Chen, and Jiemei Song, and Jinzheng Wang, and Chang Xu, and Caiping Chen, and Wei Gu, and Hongbin Sun, and Xiaoan Wen
Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors.
January 2021, Bioorganic & medicinal chemistry,
Chao Chen, and Jiemei Song, and Jinzheng Wang, and Chang Xu, and Caiping Chen, and Wei Gu, and Hongbin Sun, and Xiaoan Wen
Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
April 2016, Bioorganic chemistry,
Chao Chen, and Jiemei Song, and Jinzheng Wang, and Chang Xu, and Caiping Chen, and Wei Gu, and Hongbin Sun, and Xiaoan Wen
Design, synthesis and biological evaluation of 2-aminopyridine derivatives as USP7 inhibitors.
December 2022, Bioorganic chemistry,
Chao Chen, and Jiemei Song, and Jinzheng Wang, and Chang Xu, and Caiping Chen, and Wei Gu, and Hongbin Sun, and Xiaoan Wen
Synthesis and Biological Evaluation of Thiazole-Based Derivatives as Potential Acetylcholinesterase Inhibitors.
July 2021, ACS omega,
Chao Chen, and Jiemei Song, and Jinzheng Wang, and Chang Xu, and Caiping Chen, and Wei Gu, and Hongbin Sun, and Xiaoan Wen
Synthesis and biological evaluation of some thiazole derivatives as new cholinesterase inhibitors.
June 2013, Journal of enzyme inhibition and medicinal chemistry,
Chao Chen, and Jiemei Song, and Jinzheng Wang, and Chang Xu, and Caiping Chen, and Wei Gu, and Hongbin Sun, and Xiaoan Wen
Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
September 2014, Bioorganic & medicinal chemistry letters,
Chao Chen, and Jiemei Song, and Jinzheng Wang, and Chang Xu, and Caiping Chen, and Wei Gu, and Hongbin Sun, and Xiaoan Wen
Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
November 2014, Bioorganic & medicinal chemistry letters,
Chao Chen, and Jiemei Song, and Jinzheng Wang, and Chang Xu, and Caiping Chen, and Wei Gu, and Hongbin Sun, and Xiaoan Wen
Design, synthesis and biological evaluation of novel thiazole-derivatives as mitochondrial targeting inhibitors of cancer cells.
September 2021, Bioorganic chemistry,
Copied contents to your clipboard!